azithromycin prophylaxis cystic fibrosis
(Reuters) – The plan to roll out Merck & Co’s promising antiviral pill to treat COVID-19 risks repeating the inequities
Read more(Reuters) – The plan to roll out Merck & Co’s promising antiviral pill to treat COVID-19 risks repeating the inequities
Read more(Reuters) -Merck & Co is buying Acceleron Pharma Inc for about $11.5 billion, broadening its portfolio beyond aging cancer drug
Read more